MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Sarepta Therapeutics, Inc. (NASDAQ: SRPT)
*Key People: Sarepta
Parents
*Key People: Industry
Sarepta Therapeutics, Inc. (NASDAQ: SRPT)
Children
2013: Look Who’s Hiring in Biotech: Companies That Are Built to Last (2013)
2025: Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move
2025: Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks
Douglas S. Ingram, Sarepta Therapeutics, Inc. - President, CEO & Director (2021)
Gilmore O'Neill, Sarepta Therapeutics, Inc. - Executive VP of R&D and Chief Medical Officer (2021)
Louise Rodino-Klapac, Sarepta Therapeutics, Inc. - Executive VP & Chief Scientific Officer (2021)
Number of employees: 1,162 (2022)
Jumps
Finance & Acquisitions: Sarepta
Organization & Developments: Sarepta